Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. SEI Pharmaceuticals, Inc.
WARNING LETTER
•SEI Pharmaceuticals, Inc.•September 29, 2011

SEI Pharmaceuticals, Inc. – FDA Warning Letter, Sep 29, 2011

Record Details

On March 26, 2012, the FDA issued a Warning Letter to SEI Pharmaceuticals, Inc. following an inspection from September 19-29, 2011, at their Miami, Florida facility. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations for dietary supplements (21 CFR Part 111), rendering their products adulterated under Section 402(g)(1) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. Failure to establish and follow written procedures for quality control operations (21 CFR 111.103). 2. Failure to verify finished dietary supplement batches met product specifications for identity, purity, strength, composition, and contamination limits (21 CFR 111.75(c)). 3. Failure to prepare and follow written Master Manufacturing Records (MMRs) for each unique formulation and batch size (21 CFR 111.205(a)). 4. Failure to prepare a batch production record for each manufactured batch (21 CFR 111.255(a)). 5. Failure to establish written procedures for laboratory operations and testing (21 CFR 111.303). 6. Failure to maintain, clean, and sanitize equipment, utensils, and contact surfaces, with observed residue on funnels

Company
SEI Pharmaceuticals, Inc.
Inspection date
September 29, 2011
Product type
Food
Office
Florida District Office
Person
  • Emma R. Singleton (District Director)
View Company Profile

ID · 26d26877-46a3-44d3-b924-f4da538739c2

Violation Codes10
21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.10321 CFR 111.75(c)21 CFR 111.205(a)21 CFR 111.255(a)21 CFR 111.30321 CFR 111.27(d)21 CFR 111.40321 CFR 111.453

Full citation text and observation details available on the Dashboard.

Other documents for SEI Pharmaceuticals, Inc.
  • WARNING_LETTER

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SEI Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.